Nexavar® (sorafenib) – PRODUCT INFORMATION

NEXAVAR is a prescription, anticancer medicine used to treat adults with kidney cancer. NEXAVAR is a multi-kinase inhibitor, one of a new class of therapies often called targeted therapy. The growth of new blood vessels and the growth of new cells are two processes that do not function normally in tumors. According to the manufacturer’s website, NEXAVAR is designed to interfere with these processes. By reducing the supply of blood to the tumor and by slowing tumor growth, NEXAVAR may prevent the growth and spread of cancer.

For more information, please visit Nexavar.com or download the full prescribing information.

Nexavar is a registered trademark of Bayer Pharmaceuticals Corporation.